July 1, 2026 · Form 4 insider transaction
Goodman Noah sold 3,389 shares of Kymera Therapeutics, Inc. at $114.29 per share, a transaction worth $387.3K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.
These transactions were effected pursuant to a Rule 10b5-1 trading plan dated December 10, 2025 adopted by the reporting person.; This number includes 373 shares acquired under the Registrant's employee stock purchase plan.